Innova CaptabBOM:544067 -1.82%46 Dividend Yield % is 0.20% as of Jul. 01, 2026, which is 17% below its 10-year median of 0.24. GuruFocus rates BOM:544067 with a GF Score™ of 46/100. The stock has 6 warning signs investors should review. Among 517 Drug Manufacturers companies, Innova Captab ranks worse than 93.62% on this metric.
As of today (2026-07-01), the Trailing Annual Dividend Yield of Innova Captab is 0.20%.
Warning Sign:
Innova Captab Ltd stock Dividend Yield % is close to 1-year low.
The historical rank and industry rank for Innova Captab's Dividend Yield % or its related term are showing as below:
BOM:544067'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.2 Med: 0.24 Max: 0.29
Current: 0.2
During the past 8 years, the highest Dividend Yield of Innova Captab was 0.29%. The lowest was 0.20%. And the median was 0.24%.
BOM:544067's Dividend Yield % is ranked worse than 93.62% of 517
companies
in the Drug Manufacturers industry
Industry Median: 2.04
vs BOM:544067: 0.20
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Innova Captab's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544067 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innova Captab Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Innova Captab's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Innova Captab's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Innova Captab Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 2.000000
2026-01-30
2026-01-30
2026-02-12
Cash Dividend
semi-annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Innova Captab's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innova Captab (BOM:544067) has a Dividend Yield % of 0.20% as of Jul. 01, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Innova Captab and its competitors. This is 17% below median its historical median of 0.24. Over the past decade, Innova Captab's Dividend Yield % has ranged from 0.20 to 0.29. According to the industry distribution chart, Innova Captab ranks #484 out of 517 companies in the Drug Manufacturers industry, placing it in the top 93.6%.
Is Innova Captab's Dividend Yield % too high?
Innova Captab's current Dividend Yield % of 0.20% is 17% below median its 10-year median of 0.24. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 0.29. The Drug Manufacturers industry median Dividend Yield % is 2.04. Innova Captab's value of 0.20% is 90.2% below this industry median. Based on the distribution chart, Innova Captab ranks #484 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Innova Captab has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Innova Captab ranks #484 out of 517 companies for Dividend Yield %. This places Innova Captab in the lower half of its industry. The industry median Dividend Yield % is 2.04. Innova Captab's value of 0.20% is 90.2% below this benchmark. Historically, Innova Captab's own Dividend Yield % has ranged from 0.20 to 0.29 over the past decade. While the company's 10-year median is 0.24 vs. the industry median of 2.04, Innova Captab has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.04, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innova Captab's current Dividend Yield % of 0.20% is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Innova Captab and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innova Captab's current Dividend Yield % is 0.20%, which is 17% below median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (BOM:544067) has a current Dividend Yield % of 0.20%. The current Dividend Yield % is 0.20%, which is 17% below median its 10-year median of 0.24 and 90.2% below the Drug Manufacturers industry median of 2.04. Innova Captab's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Innova Captab (BOM:544067), the current Dividend Yield % is 0.20% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
46GF Score
Get the complete analysis for BOM:544067
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544067 has been successfully added to your 
